Comment www.thelancet.com Vol 396 July 18, 2020 145In patients having cardiac and non-cardiac surgery, new-onset postoperative atrial fibrillation and postoperative delirium have been associated with several adverse long-term outcomes, including increased cardiovascular, renal, and cerebral complications, worsened postoperative cognitive function, increased mortality, longer length of stay in hospital, and increased medical costs.1–3 Identifying effective therapies and modifiable factors that might reduce the incidence of postoperative atrial fibrillation and postoperative delirium is paramount
Bilotta, F., Pugliese, F. (2020). The evolving clinical use of dexmedetomidine. THE LANCET, 396(10245), 145-147 [10.1016/S0140-6736(20)30902-8].
The evolving clinical use of dexmedetomidine
Bilotta F.;
2020-01-01
Abstract
Comment www.thelancet.com Vol 396 July 18, 2020 145In patients having cardiac and non-cardiac surgery, new-onset postoperative atrial fibrillation and postoperative delirium have been associated with several adverse long-term outcomes, including increased cardiovascular, renal, and cerebral complications, worsened postoperative cognitive function, increased mortality, longer length of stay in hospital, and increased medical costs.1–3 Identifying effective therapies and modifiable factors that might reduce the incidence of postoperative atrial fibrillation and postoperative delirium is paramount| File | Dimensione | Formato | |
|---|---|---|---|
|
Bilotta_Evolving-use-dexmedetomidine_2020.pdf
non disponibili
Licenza:
Copyright dell'editore
Dimensione
307.37 kB
Formato
Adobe PDF
|
307.37 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
